Efficacy and safety of Suhuang Zhike capsule for cough variant asthma: a multicenter, single-arm, open-label phase IV real-world clinical trial.
Suhuang Zhike capsules demonstrated good efficacy and safety for the treatment of CVA. These findings offer valuable clinical evidence to support their broader application in routine clinical practice.
Authors
- Yang Dao-wen
- Ying Li (ORCID: https://orcid.org/0000-0002-4041-2646)
- Yan Huang (ORCID: https://orcid.org/0000-0002-3151-5555)
- Jian Liu (ORCID: https://orcid.org/0000-0001-7272-8218)
- Zhuyin Li
- Hongchun Zhang (ORCID: https://orcid.org/0000-0001-7390-6995)
- Sheng Chen (ORCID: https://orcid.org/0000-0003-3530-1287)
- Lei Xiang (ORCID: https://orcid.org/0000-0003-4197-412X)
- YU Xue-qing
- Zhang Wei
- Wei Baolin
- Pei Shuai
- Guo Jianning
- L U Xuechao
- S U Lianhua
Institutions
- Academy of Medical Sciences (GB)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- China-Japan Friendship Hospital (CN)
- National Institute of Integrative Medicine (AU)
- National Clinical Research (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-08-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.04.011
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00